CAS: 113893-08-6; Benzo[b]Thiophen-3-Ylboronic Acid

该化合物是一种有机有机体化合物,其特征是附于苯并对硫环系的碳酸功能组,该化合物通常具有与芳香化合物和异环化合物有关的特性,包括由于黄酸酸合金而具有的稳定性和再活性;已知的黄酸组有能力与二醇形成可逆的共价结合,使其在诸如铃木合金有机合成中的反应等各种应用中有用;苯并硫衍生物往往表现出有趣的电子特性,在材料科学中,特别是在有机半导体和光伏装置中,可以加以利用;此外,苯并苯结构中存在硫,可产生独特的化学再活性,影响化合物的溶解性和与生物系统的互动;

结构式图片

相似化合物

171364-86-6 177735-30-7 628692-17-1

欧盟法规

C&L通报

上下游产品

CAS号7342-82-7 3-溴苯并噻吩 | CAS号5419-55-6 硼酸三异丙酯

合成工艺路线路线简述

  • 合成目标产物 Benzothiophene-3-Boronic Acid 主要起始原料 3-Bromo-1-Benzothiophene And Triisopropyl Borate
  • (文献来源)合成步骤主要原料 3-Bromo-1-Benzothiophene 和 Triisopropyl Borate
苯并噻吩置于三苯基硼烷体系中,用 二氯甲烷,水 用作溶剂,化学反应 0.5H,反应生成苯并噻吩-3-硼酸
参考文献:一种苯并杂环-3-硼酸的制备方法
标题:一种苯并杂环-3-硼酸的制备方法
摘要:本发明公开了一种苯并杂环‑3‑硼酸的制备方法,属于有机硼酸化学技术领域.从苯并杂环出发,在催化剂存在下,与三卤化硼选择性付克反应,水解后得到苯并杂环‑3‑硼酸.本发明中通过选择合适的催化剂和反应条件,通过高选择性在杂环3位进行定位,水解后得到硼酸,利用2位和3位硼酸性质的差异,经过纯化后得到苯并杂环‑3‑硼酸.该方法为苯并杂环‑3‑硼酸提供了较为简洁的合成路径,收率较高,异构体纯化较为容易.

海关参考信息

专利信息


专利号:US-9370515-B2
优先权日:2013-03-07
标题 :Mixed lineage kinase inhibitors and method of treatments
发明人:GOODFELLOW VAL S; NGUYEN THONG X; RAVULA SATHEESH B; GELBARD HARRIS A
权利人:CALIFIA BIO INC; UNIV ROCHESTER
摘要:Provided herein are imidazopyridine compounds having an inhibitory effect on mixed lineage kinases (MLKs), methods of their synthesis, and methods of their therapeutic. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and pharmaceutical compositions.

专利号:US-2009137566-A1
优先权日:2005-05-26
标 题 :Substituted Piperdines as Renin Inhibitors
发明人:EHARA TAKERU; HITOMI YUKO; KONISHI KAZUHIDE; MASUYA KELICHI
权利人:EHARA TAKERU; HITOMI YUKO; KONISHI KAZUHIDE; MASUYA KELICHI
摘要:The invention relates to substituted 3,4- or higher substituted piperididine compounds, the use thereof for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; pharmaceutical formulations or products comprising said compounds, and/or a method of treatment comprising administering said compounds, a method for the manufacture of said compounds, as well as novel intermediates, starting materials and/or partial steps for their synthesis. The compounds preferably have the formula I, n n n n n n n n n n wherein the moieties R1, R2, R11 and W are as defined in the specification.

专利号:US-2009137557-A1
优先权日:2005-11-22
标题 :Calcilytic Compounds
发明人:KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S
权利人:KU THOMAS WEN FU; LIN HONG; LUENGO JUAN I; MARQUIS JR ROBERT W; RAMANJULU JOSHI M; TROUT ROBERT; YAMASHITA DENNIS S
摘要:Novel calcilytic compounds, pharmaceutical compositions, methods of synthesis and methods of using them are provided.

专利号:CN-118164909-A
优先权日:2024-04-22
标 题:Synthesis method of non-activated olefin selective arylation

专利号:CN-114835625-A
优先权日:2022-06-23
标 题 :A kind of axial chiral indole derivatives containing 2-thiocyano-3-aryl group synthesis method
维赛诺化学技术(北京)有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.vscichem.com
企业联系电话:13811761079👤
📞维赛诺化学技术(北京)有限公司 ⚠️参考联系方式
联系人:黎经理
电话:13811761079
手机:13811761079

邮箱:vscichem@163.com
通信地址: 北京市石景山八大处高科技园区西井路3号3号楼5575房间
邮编: 102600
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:北京市石景山八大处高科技园区西井路3号3号楼5575房间
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Gao, W.-C.; Tian, J., Science of Synthesis Knowledge Updates, (2020) 3, 259.
摘要:Bottecchia, C.; Noël, T., Science of Synthesis: Flow Chemistry in Organic Synthesis, (2018) 1, 314.
摘要:Xu, C.; Shao, X.; Shen, Q., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 32.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知